Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer announce positive results for Humira biosimilar

January 6, 2017
Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …

News

Pfizer announces acquisition of small-molecule business from AZ for $550 million

December 23, 2016
Medical Communications AstraZeneca, Pfizer

Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …

News
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016
Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …

News

Pfizer’s next blockbuster given FDA approval

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …

News

Pfizer slapped with record £84.2 million fine for 2,600% price increase

December 7, 2016
Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine

Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …

News

Pfizer teams up with IBM Watson Health in immuno-oncology

December 2, 2016
Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm

Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …

News
pfizer_building2web

Pfizer scraps €400m Dublin facility expansion

November 28, 2016
Manufacturing and Production, Sales and Marketing Pfizer, bococizumab

Pfizer has U-turned on its intention to bolster operations at its Grange Castle, Dublin facility in a 34,500 square-metre expansion …

News

Pfizer set to develop new $200 million site

November 23, 2016
Manufacturing and Production, Research and Development Pfizer, manufacturing and production

Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site …

News
pfizer_brussels

Pfizer sues Texas agency over leak of drug prices

November 21, 2016
Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas

Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …

News

Pfizer’s Celebrex found to be safe on hearts after 10-year clinical study

November 14, 2016
Medical Communications, Sales and Marketing Pfizer, celebrex, ibuprofen, naproxen

Pfizer’s drug, Celebrex, has been vindicated as of equivalent safety, or better, than ibuprofen and naproxen, after a 10-year study. …

News

Pfizer’s breast cancer drug gets EU approval

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …

News

Pfizer to shut two out of three manufacturing plants in UK

November 9, 2016
Manufacturing and Production, Research and Development Pfizer, UK, manufacturing, production, sites

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …

News

Pfizer surprises industry by ending development of projected blockbuster

November 1, 2016
Research and Development Pfizer, cholesterol, clinical trials

Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …

News

EMA has validated Merck and Pfizer’s MAA for avelumab

November 1, 2016
Manufacturing and Production, Sales and Marketing EMA, Merck KGaA, Pfizer, avelumab

The European Medicines Agency has validated the Marketing Authorisation Application for avelumab for the proposed indication of metastatic Merkel cell …

News
novartis_outside_1

Novartis breast cancer drug secures FDA fast-track status

November 1, 2016
Manufacturing and Production, Sales and Marketing Novartis, Pfizer, ibrance, letrozole, riboclib

Novartis has announced that its product ribociclib (LEE011) has been granted fast-track review status as a first-line treatment of advanced …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026